Back to library

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

GLP-1 Agonist · Metabolic

Dulaglutide (Trulicity)

Once-weekly GLP-1 agonist with cardiovascular benefit.

FDA-Approved

Plain-Language Label Highlights

Brand names: Trulicity

What it's approved for

Type 2 diabetes; also reduces cardiovascular events in adults with T2D and cardiovascular risk.

A once-weekly pen that mimics a gut hormone — lowering blood sugar and offering heart benefits.

Boxed Warning

Thyroid C-cell tumor risk in rodents — avoid with medullary thyroid cancer or MEN 2.

Common side effects
  • Nausea
  • Diarrhea
  • Vomiting
  • Abdominal pain
  • Decreased appetite
Serious risks to know
  • Pancreatitis
  • Hypoglycemia (with insulin/sulfonylurea)
  • Acute kidney injury
  • Severe GI reactions
Who should avoid or use with extra caution
  • Medullary thyroid cancer history
  • MEN 2

Educational summary of the FDA prescribing information. Not a substitute for the full label or medical advice. Always discuss with a licensed prescriber.

Mechanism of Action

GLP-1 analog fused to a modified human IgG4 Fc fragment, giving a half-life that supports weekly dosing. Improves glycemia and reduces MACE in T2D.

Research Areas

Type 2 diabetes
Cardiovascular risk reduction in T2D

Common Research Protocols

Weekly

0.75–4.5 mg SC once weekly.

Protocols summarized for educational reference from published research. Not dosing guidance.

Cited Research

[1]Lancet·2019

REWIND trial

Reduced major adverse cardiovascular events in T2D patients with or without prior CV disease.

Important Considerations

  • FDA-approved.
  • Boxed warning: thyroid C-cell tumors in rodents.

Explore more peptides

Educational Information Only — Not Medical Advice

All content on this page is for educational and informational purposes only. It is not medical advice, diagnosis, or treatment. We make no claims that any peptide can diagnose, treat, cure, or prevent any disease. Peptides discussed are not FDA-approved for the indications listed unless explicitly stated otherwise.

Always consult a licensed healthcare provider before beginning any wellness protocol. Statements have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability, eligibility, and pricing may vary.

Searching the library…

Ask the Library

Ask anything about peptides — answers come from our curated reference library with citations.

Find a pharmacy that carries Dulaglutide (Trulicity)

Leave your details and a vetted partner pharmacy will reach out with availability and pricing.